ZA85529B - Topical drug release system - Google Patents

Topical drug release system

Info

Publication number
ZA85529B
ZA85529B ZA85529A ZA85529A ZA85529B ZA 85529 B ZA85529 B ZA 85529B ZA 85529 A ZA85529 A ZA 85529A ZA 85529 A ZA85529 A ZA 85529A ZA 85529 B ZA85529 B ZA 85529B
Authority
ZA
South Africa
Prior art keywords
drug
phase
liquid
phases
drug release
Prior art date
Application number
ZA85529A
Other languages
English (en)
Inventor
Adrian Francis Davis
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA85529B publication Critical patent/ZA85529B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Confectionery (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA85529A 1984-01-25 1985-01-23 Topical drug release system ZA85529B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848401965A GB8401965D0 (en) 1984-01-25 1984-01-25 Composition

Publications (1)

Publication Number Publication Date
ZA85529B true ZA85529B (en) 1985-11-27

Family

ID=10555518

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA85529A ZA85529B (en) 1984-01-25 1985-01-23 Topical drug release system

Country Status (11)

Country Link
US (1) US4767751A (da)
EP (1) EP0151953B1 (da)
JP (1) JPS60174715A (da)
AT (1) ATE71519T1 (da)
AU (1) AU576344B2 (da)
CA (1) CA1249520A (da)
DE (1) DE3585162D1 (da)
DK (1) DK163799C (da)
GB (1) GB8401965D0 (da)
IE (1) IE57733B1 (da)
ZA (1) ZA85529B (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
EP0252459A1 (en) * 1986-07-07 1988-01-13 Schering Corporation Compartmentalized transdermal delivery system
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
IN168400B (da) * 1987-01-30 1991-03-23 Colgate Palmolive Co
US4894220A (en) * 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5178851A (en) * 1987-01-30 1993-01-12 Colgate-Palmolive Company Antiplaque antibacterial oral composition
US5180578A (en) * 1987-01-30 1993-01-19 Colgate-Palmolive Company Antibacterial antiplaque anticalculus oral composition
US4935225A (en) * 1987-09-11 1990-06-19 Curtis John P Appetite suppresant dentifrice
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
GB9025711D0 (en) * 1990-11-27 1991-01-09 Beecham Group Plc Topical composition
ATE183639T1 (de) * 1991-02-18 1999-09-15 Commw Scient Ind Res Org Zusammensetzung zur verwendung in der transdermalen verabreichung
GB9118711D0 (en) * 1991-08-31 1991-10-16 Smithkline Beecham Plc Novel device
GB9125712D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
GB9205194D0 (en) * 1992-03-10 1992-04-22 Smithkline Beecham Plc Novel composition
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US5290541A (en) * 1992-06-18 1994-03-01 The Procter & Gamble Company Methods for making oral compositions
FI944321A7 (fi) * 1992-11-05 1994-11-16 Becton Dickinson Co Käyttäjäaktivoitu iontoforeettinen laite ja menetelmä sen käyttämiseks i
US5474761A (en) * 1993-04-08 1995-12-12 The Procter & Gamble Company Oral compositions for treating plaque and gingivitis
US5290542A (en) * 1993-04-08 1994-03-01 The Procter & Gamble Company Oral compositions for treating plaque and gingivitis
US5807569A (en) * 1993-05-27 1998-09-15 Smithkline Beecham P.L.C. Topical composition
WO1995004520A1 (en) * 1993-08-06 1995-02-16 Embro William J Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions
US5900249A (en) * 1998-02-09 1999-05-04 Smith; David J. Multicomponent pain relief topical medication
US6765019B1 (en) 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
WO2003059194A2 (en) * 2001-12-21 2003-07-24 Alcon, Inc. Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
BR0215149A (pt) * 2001-12-21 2004-10-19 Alcon Inc Uso de nanopartìculas inorgânicas para modificar a viscosidade e outras propriedades fìsicas de composições farmacêuticas e óticas
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
WO2005120487A2 (de) * 2004-06-11 2005-12-22 Egon Tech Präparat zur prophylaxe und therapie von stresszuständen, von funktionellen und organischen störungen des nervensystems und des stoffwechsels
EP2457560A1 (en) 2006-06-14 2012-05-30 Dr Reddy's Laboratories Limited Topical compositions
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
US8114159B2 (en) * 2006-11-20 2012-02-14 Depuy Spine, Inc. Anterior spinal vessel protector
CA2784827C (en) * 2009-12-16 2018-10-23 Shasun Pharmaceuticals Limited Composition of dexibuprofen transdermal hydrogel
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
JP5989095B2 (ja) 2011-05-03 2016-09-07 アポニア ラボラトリーズ インコーポレイテッド イブプロフェンの経皮組成物およびその使用方法
KR102643849B1 (ko) 2015-06-18 2024-03-07 밸리언트 파마슈티컬즈 노오쓰 아메리카 엘엘씨 건선을 치료하기 위한 코르티코스테로이드 및 레티노이드를 포함하는 국소 조성물
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
EP3870150A1 (en) 2018-10-26 2021-09-01 Viramal Limited Mucoadhesive gel composition
ES2948955T3 (es) 2018-11-30 2023-09-22 Viramal Ltd Un método de preparación de un agente gelificante, el agente gelificante obtenido de este modo y el uso de dicho agente gelificante
JP2024540701A (ja) 2021-11-08 2024-11-01 リー・ウェイヨン 患者に薬物を送達するための経皮薬物送達システム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582207A (en) * 1977-05-16 1981-01-07 Sanol Arznei Schwarz Gmbh Stable isosorbide dinitrate solutions preparation thereof and use thereof
US4140656A (en) * 1977-10-07 1979-02-20 Armour-Dial, Inc. Anhydrous clear gel facial cleanser
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition

Also Published As

Publication number Publication date
US4767751A (en) 1988-08-30
ATE71519T1 (de) 1992-02-15
AU3800885A (en) 1985-08-01
IE57733B1 (en) 1993-04-07
EP0151953B1 (en) 1992-01-15
DK163799C (da) 1992-08-31
CA1249520A (en) 1989-01-31
DK163799B (da) 1992-04-06
EP0151953A3 (en) 1987-01-21
GB8401965D0 (en) 1984-02-29
EP0151953A2 (en) 1985-08-21
IE850146L (en) 1985-07-25
AU576344B2 (en) 1988-08-25
DK30585A (da) 1985-07-26
DE3585162D1 (de) 1992-02-27
JPH0430923B2 (da) 1992-05-25
DK30585D0 (da) 1985-01-23
JPS60174715A (ja) 1985-09-09

Similar Documents

Publication Publication Date Title
EP0151953A3 (en) Topical drug release system
EP0289342A3 (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
ATE95057T1 (de) Oertliches arzneimittel mit verzoegerter wirkstoffabgabe.
MY101570A (en) Novel pharmaceutical compositions for topical application with systemic action
DE3067536D1 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
IL82192A0 (en) System for administration of drugs to the skin and process for the preparation thereof
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
EP0224981A3 (en) Nitroglycerin transdermal delivery system
ZA879248B (en) Topical drug release system
EP0195605A3 (en) Process of making gelled cellulose triacetate product and a product made thereby
HK100590A (en) Soluble and/or splitable tablets
NL7603594A (nl) Werkwijze voor het bereiden van carbonzuuramiden, alsmede de toepassing daarvan als farmaceutische preparaten.
MY108692A (en) Topical composition
ES8701490A1 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
TW269636B (en) Once-daily transdermal pharmaceutical composition of nicotine for the treatment of withdrawal symptoms associated with smoking cessation
JPS5572108A (en) Preparation for transcutaneous administration, composed mainly of nitroglycerine
Cheng et al. Intrauterine injection of 20 per cent saline for inducing abortion
KR890001567A (ko) 디플루니살 및 트로메타민-함유 조성물
TH360B (th) น้ำลูกยอผสมน้ำผึ้ง
NO173168C (no) Anordning for avgivelse av aktive bestanddeler til huden
TH1599A (th) ยาปลูกผม